Introduction
Despite a marked improvement in survival following coronary heart disease (CHD) through major therapeutic advances in the last few decades, CHD remains the leading cause of years of lost life in 2013 according to the global burden of diseases analyses and the most common cause of death in Europe. 1, 2 In France, CHD was the second cause of death after stroke among women in 2013, ahead of breast cancer. 1 Although the incidence of cardiovascular events was lower in women than in men, results of several studies have recently highlighted the necessity to focus closely on women for several reasons. Indeed, women with acute coronary syndrome (ACS), especially young women are more likely to present atypical symptoms. A consequence of these atypical symptoms is often an underestimation of the severity and a longer delay between symptoms and the first call to an emergency unit in women compared with men. [3] [4] [5] In addition, a recent French study reported that once the first contact with an emergency unit was made, the delay for a first medical contact was longer in women than in men. 3 Finally, a higher in-hospital mortality in women presenting a ST-elevation myocardial infarction (STEMI) has been reported in many studies, even after adjustment tion in women, the pathophysiology of STEMI, the anatomic specificities of coronary arteries in women, and the higher risk of bleeding in women could partly explain sex difference in prognostic.
Irrespective of the possible difference in short-term mortality between men and women, the recent evidence of an increasing proportion of women aged under 60 years among STEMI patients is a matter of considerable concern. 7 However, the results of this study need to be confirmed on a larger scale and over a more recent period.
In this context, we aimed to analyse trends in annual rate of patients hospitalized ACS in France from 2004 to 2014 using an exhaustive and nationwide administrative database, and describe trends by age, sex and type of ACS.
Methods
Annual hospital discharge data from 2004 to 2014 were obtained from the French National Hospitalization Database ['Programme de médical-ization des systèmes d'information-Médecine, chirurgie, obstétrique' (PMSI-MCO)]. Only full hospitalizations (i.e. including at least one night in hospital) of people living in France (metropolitan and French overseas territories, except Mayotte island) were considered. We studied all hospital discharge summaries where one of the following codes, from the 10th revision of the International Classification of Diseases (ICD-10), was recorded for primary diagnosis of ACS: I20.0 (Unstable Angina (UA)) and I21-23 (historic codes for acute myocardial infraction (AMI)). Among AMI, ST-elevation MI (STEMI) were approximated by using the I21.0, I21.1, I21.2, and I21.3 codes and others AMI codes were classified as non-ST-elevation MI (NSTEMI).
In order to estimate annual rates, we only selected the first hospitalization for ACS of each year when a patient had several hospital admissions for ACS. Hospital stays during less than 2 days and ending by a transfer to another unit or hospital were also excluded in order to avoid double count of patients in case of short stay.
To compute rates among the whole French population, mean annual estimations of the French population by age and sex were obtained for the years between 2004 and 2014 from the National Institute of statistic and economic studies ['Institut national de la statistique et des études économiques' (Insee)].
For each year, rates of patients hospitalized for ACS were calculated, and stratified by age, sex, and subtypes of ACS. Age-standardized rates were estimated using standardization on the census of the 2010 European population. In-hospital mortality rate was defined as the ratio between the number of patients hospitalized for ACS and dying during the hospital stay, and the overall number of patients admitted for ACS. The mean length of stay, the mean age at admission, and death were assessed.
Sex comparisons were estimated by t-tests for quantitative characteristics (age, length of stay) and by v 2 tests for qualitative variables. Mean annual percent changes were estimated by using Poisson regression models with mean annual population as offset statement and linear trends for time representation. Due to overdispersion, a quasi-Poisson distribution was applied. Analyses were conducted for all ACS patients first and then separately among STEMI, NSTEMI, and UA. Interaction between sex and time was tested. Trends in mean age and mean length of stay were estimated by simple linear regression. The statistical analysis was performed using SAS enterprise Guide 7.1.
Results
Characteristics of patients hospitalized for acute coronary syndrome in 2014
In 2014, 113 407 patients, 36 480 women (32.2%) and 76 927 men (67.8%) were hospitalized for ACS ( Table 1) . Mean age at hospital admission was higher in women (73.8 years old) than in men (65.8 years old). The proportion of patients aged <65 years was 25.2% among women (n = 9206) and 46.7% among men (n = 35 901). Among women, mean length of stay was 6.4 days (5.6 among men). Inhospital mortality was higher in women (6.4%) than in men (3.4%), especially for STEMI (12.0% in women vs. 5.7% in men). The agestandardized rate of patients hospitalized for ACS was approximatively three times lower in women compared to men. Among ACS patients, 36.3% had STEMI, 17.1% NSTEMI, and 46.6% UA. Distribution of ACS subtypes annual incidence among population aged under 65 showed lower rates of STEMI in women compared to men but greater rates of UA ( Figure 1 ).
Time trends in rates of patients hospitalized for acute coronary syndrome by age, sex, and acute coronary syndrome subtypes Overall acute coronary syndrome From 2004 to 2014, the overall rates of age-standardized admissions for ACS decreased in both women (-17.1%) and men (-14.0%). After 65 years of age, a more significant decrease was observed in both women (-23.0%) and men (-17.9%) ( Figure 2 ). Conversely, before 65 years of age, rates of women hospitalized for ACS increased by 6.3%. Analyses of mean annual trends by age group from 2004 to 2014 showed a significant increase in the rate of patients hospitalized for ACS in women aged between 45 and 64 years old. The greatest increase was observed among those aged 45-54 years old (þ1.7% per year) ( Figure 3A) . In men from 45 to 64 years of age, trends were not significant.
Acute coronary syndrome subtypes Differential trends were observed by age and ACS subtypes. After 65 years of age, a significant decrease was observed for all types of ACS. Rates of STEMI, NSTEMI, and UA admissions decreased respectively by 28.7, 23.1, and 18.5% in women. Similar trends were observed in men aged > _65 years.
Before 65 years of age, rates of women hospitalized for STEMI and NSTEMI increased by 21.7% and 53.7%, respectively whereas rates of women hospitalized for UA decreased by 10.2% (Figure 2) . Mean annual percent change in rates of STEMI increased substantially from 2004 to 2014 in people aged under 65 years, particularly in women (þ3.6% per year for age 45-54 years and þ2.0% per year for age 55-64 years) compared to men (þ0.6% per year for age 45-54 years and no significant change for age 55-64 years) ( Figure 3B ). For NSTEMI, rates increased markedly in women under 65 years of age were unchanged in those from 65 to 74 years, and decreased in women > _75 years; in men, rates increased for all age classes below 75 years, were unchanged in men 75-84 years and decreased in men > _85 years ( Figure 3C ). In contrast, decreases in rates of UA were observed in women and men across all age groups, except for women aged Overall these different trends resulted in a significant decrease of mean age at ACS admission in women but in an increase in men, from 2004 to 2014. Additionally, mean length of stay decreased significantly by around 5% over the study period in both sex and whatever ACS subtypes.
Discussion
This is the first nationwide study describing recent trends in rates of patients hospitalized for ACS in France, with a focus on sex differences. Despite an overall decrease in age-standardized admissions for ACS in both women and men, we observed a global increase of 6.3% from 2004 to 2014 among women aged <65 years. The increase was particularly marked (þ21.7%) for women <65 years hospitalized for STEMI, especially among the 45-54-year and 55-64-year age groups with respective mean annual percent changes of 3.6 and 2.0% per year. Similar unfavourable trends were observed for NSTEMI in both women and men.
The increase in STEMI rates in women aged <65 years is in keeping with data from the French USIC and FAST-MI hospital registries, which reported an increase in the proportion of women aged <60 years among patients hospitalized for STEMI from 1995 to 2010. 7, 9 In the USA, as in other European countries, studies on ACS, AMI, or UA admissions did not consistently report similar patterns in younger women. In several studies, the incidence rates decreased or plateaued with similar changes in both women and men. [10] [11] [12] [13] [14] In the MONICA experience, the AMI attack rates in younger individuals (<65 years) declined in a similar fashion for women (-3.3%) and men (-3.7%) from 1985 to 2010. 10 Regarding the population aged > _65 years, our results are consistent with data of other countries. However, none of these studies specifically assessed the evolution of rates of AMI according to AMI type. The increase in ACS hospitalizations in younger women observed in our study was largely driven by the increase in AMI hospitalizations among women aged 45-64 years. Similar changes have been recorded for ischaemic stroke incidence in young French people from the stroke registry of Burgundy. 15 This increase in young women is likely related to a concomitant rise in the prevalence of cardiovascular risk factors, particularly smoking. In a 2014 French national survey estimating health characteristics in a representative sample of the French population, the prevalence of regular tobacco smoking increased considerably in women aged 45-74 years from 2005 to 2014 and doubled in the 55-64 years age group. Prevalence of smoking also increased among AMI patients according to FAST-MI registries, especially among STEMI patients. 7, 9 Moreover, smoking was pointed out as the most important modifiable risk factor with AMI incidence in the INTERHEART study. 16 Another potential reason for the unfavourable trends among younger women could be the fast growing proportion of obesity among women (þ43% in women aged 55-64 years between 1997 and 2012). 17, 18 Prevalence of others cardiovascular risk factors such as hypertension, hypercholesterolemia or diabetes were less likely to have changed over the study period among ACS patients. 7, 9 Other factors, related to the overall lifestyle changes in younger women may also have participated in the increase noticed in this younger population, such as changes in diet and less physical activities. The decrease in ACS incidence among both women and men aged > _65 years suggests improvements in controlling cardiovascular risk factors, once they are recognized, and a better medical attention to this population. However, reliable data on the evolution of risk factors are unfortunately lacking in France. Finally, the association between ACS or AMI incidence and cardiovascular risk factors may differ between women and men. Diabetes and hypertension might be more associated to AMI risk in women than in men, especially before 60 years of age. 19, 20 As for smoking, it has been suggested that the risk of CHD among smokers was increased by 25% in women compared to men, 21 but the INTERHEART study showed that the association of smoking, hypercholesterolemia and obesity with AMI was of a similar magnitude in women and men. 19 To interpret time trends observed during the period considered in this study, changes in AMI definition, with its consequences in the categorization of ACS. The 2007 universal definition adopted by all international scientific societies introduced the systematic usage of troponin for diagnosing AMI. 22 Simultaneously, diagnostic methods have been greatly improved across the study period by detecting very low levels of myocardial necrosis. This could have entailed a substantial rise in NSTEMI cases diagnosed at the expense of UA. [23] [24] [25] Indeed, we observed a significant decline in rates of patients hospitalized for UA across all age groups except the elderly. Furthermore, technical improvements may have impacted women more than men due to higher NSTEMI occurrence in women than in men. 9 Whatever the case, the greater sensitivity in the detection of AMI with the use of troponins instead of CK-MB, and of high-sensitivity troponins instead of conventional assays would tend to increase the rates, whatever the age groups. 25 
Limitations
The main limitations of our study are related to the use of administrative databases, for which coding may not completely reflect clinical situations. A French study on ACS coding in those databases was lead in 2011 and found that I20.0, I121-23 had good positive predictive value. 26 Moreover, a review of validation studies about AMI identification in administrative databases through the use of ICD-10 codes delivered satisfactory conclusions. 27 Nevertheless, no study has analysed whether coding practices have significantly changed during the study period. Conversely, using the administrative databases also constitute the strength of our analysis, considering their exhaustive nationwide scope. Also, ICD-10 codes don't clearly discriminate STEMI from NSTEMI but only transmural MI, STEMI being not always analogous to a transmural MI according to autopsy studies. This complicated the interpretation of the results considering changes in AMI diagnostic methods and definition now integrating ACS terms. 28 Whatever the case, potential changes in coding is unlikely to have differed according to age and sex. At last, there is a lack of information in hospitalization database, so that we were not able to explore causality between observed trends and changes in risk factors prevalence. Particularly, it would have been interesting for women to compare ACS hospitalization trends with prevalence of early menopause and the use of oral contraceptives in the French population.
Conclusion
This nationwide study shows preoccupying temporal trends in the annual incidence of hospitalized STEMI and No-STEMI, especially among young women. Tobacco smoking and obesity are likely to play a role in these trends. Even if the increased incidence of ACS in women aged under 65 years would be masked by the heavy burden of ACS in men and in the elderly, its major socioeconomic impact and the lost DALYS in young women victims of ACS is of a major importance. It is urgently needed to improve primary vascular prevention in young women, particularly considering that the main risk factors are modifiable.
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